Evolution of commercially available compounds for HTS-Reference-Cited by-同舟云学术

Evolution of commercially available compounds for HTS

Published:2019-02 Issue:2 Volume:24 Page:390-402
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Volochnyuk Dmitriy M.,Ryabukhin Sergey V.,Moroz Yurii S.,Savych Olena,Chuprina Alexander^ORCID,Horvath Dragos^ORCID,Zabolotna Yuliana^ORCID,Varnek Alexandre,Judd Duncan B.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference73 articles.

1. The fall and rise of pharmacology – (re-)defining the discipline?;Winquist;Biochem. Pharmacol.,2014

2. Twenty years on: the impact of fragments on drug discovery;Erlanson;Nat. Rev. Drug Discov.,2016

3. DNA-encoded chemistry: enabling the deeper sampling of chemical space;Goodnow;Nat. Rev. Drug Discov.,2017

4. Opportunities and challenges in phenotypic drug discovery: an industry perspective;Moffat;Nat. Rev. Drug Discov.,2017

5. Diagnosing the decline in pharmaceutical R&D efficiency;Scannell;Nat. Rev. Drug Discov.,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relaxation of Steric Strains of TTR-Type Amyloid Fibril Inhibitors Radically Changes the Results of Their Virtual Screening;Cell and Tissue Biology;2024-08-12

2. High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening;Molecules;2024-07-08

3. Outline and background for the EU-OS solubility prediction challenge;SLAS Discovery;2024-06

4. Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece;Frontiers in Chemistry;2024-04-18

5. Integrated workflow for the identification of new GABA_AR positive allosteric modulators based on the in silico screening with further in vitro validation. Case study using Enamine's stock chemical space;Molecular Informatics;2024-01-24